Sign in

CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company

BIOMERICA INC

Sign in to watch
Ticker
BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
952645573
Phone
9493792875
Business address
17571 VON KARMAN AVENUE, IRVINE, CA, 92614
  1. CERTNAS Other Certification by the Nasdaq Stock Market
  2. 8-A12B Other Registration of Securities
  3. 4 Open-market buy Chief Financial Officer bought 2,200 shares at $2.98 ($6,546)
  4. 4 Open-market buy Trust of an Officer & Director bought 2,200 shares at $2.98 ($6,546)
  5. 4 Open-market buy Cheif Executive Officer bought 3,166 shares at an average $2.98 ($9,420)
  6. 4 Open-market buy Chief Executive Officer bought 3,700 shares at an average $2.88 ($10,638)
  7. 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $2.72 ($2,722)
  8. 4 Open-market buy Director bought 4,536 shares at an average $2.63 ($11,944)
  9. 4 Open-market buy Director bought 3,000 shares at an average $2.54 ($7,630)
  10. 8-K Event Other events
  11. 4 Open-market buy Director bought 16,300 shares at an average $2.37 ($38,577)
  12. 4 Open-market buy Chief Executive Officer bought 2,609 shares at an average $2.10 ($5,473)
  13. 4 Open-market buy Director bought 4,000 shares at $2.05 ($8,200)
  14. 4 Open-market buy Director bought 8,000 shares at an average $1.97 ($15,745)
  15. 4 Open-market buy Chief Executive Officer bought 5,400 shares at an average $1.88 ($10,128)
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. 8-K Event Material agreement · Unregistered share sale
  19. 4 Option exercise Director acquired 20,000 shares (option exercise)
  20. 4 Open-market sale President sold 20,000 shares at $1.50 ($30,000)

Page 16 of 31 · 605 filings